CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -66.7% | 795 | -52.6% | 0.00% | – |
| Q2 2022 | $3,000 | -72.7% | 1,677 | -61.2% | 0.00% | – |
| Q1 2022 | $11,000 | -98.1% | 4,325 | -96.7% | 0.00% | – |
| Q4 2021 | $566,000 | +1.6% | 130,769 | +19.5% | 0.00% | – |
| Q3 2021 | $557,000 | -70.8% | 109,469 | -63.7% | 0.00% | -100.0% |
| Q2 2021 | $1,906,000 | +20.8% | 301,157 | +47.5% | 0.00% | 0.0% |
| Q1 2021 | $1,578,000 | +2004.0% | 204,155 | +1683.5% | 0.00% | – |
| Q4 2020 | $75,000 | +134.4% | 11,447 | +139.5% | 0.00% | – |
| Q3 2020 | $32,000 | -89.8% | 4,780 | -87.3% | 0.00% | – |
| Q2 2020 | $313,000 | +140.8% | 37,558 | +121.4% | 0.00% | – |
| Q1 2020 | $130,000 | +15.0% | 16,963 | +24.6% | 0.00% | – |
| Q4 2019 | $113,000 | -58.6% | 13,613 | -63.2% | 0.00% | – |
| Q3 2019 | $273,000 | -73.5% | 37,041 | -59.7% | 0.00% | -100.0% |
| Q2 2019 | $1,032,000 | +236.2% | 91,988 | +221.6% | 0.00% | – |
| Q1 2019 | $307,000 | -84.4% | 28,604 | -78.1% | 0.00% | -100.0% |
| Q4 2018 | $1,971,000 | +220.0% | 130,508 | +292.0% | 0.00% | +100.0% |
| Q3 2018 | $616,000 | -37.7% | 33,293 | -23.0% | 0.00% | 0.0% |
| Q2 2018 | $988,000 | +9.5% | 43,228 | +36.3% | 0.00% | 0.0% |
| Q1 2018 | $902,000 | +12.9% | 31,723 | -16.1% | 0.00% | 0.0% |
| Q4 2017 | $799,000 | +195.9% | 37,827 | +154.8% | 0.00% | – |
| Q3 2017 | $270,000 | +26900.0% | 14,843 | +19690.7% | 0.00% | – |
| Q2 2017 | $1,000 | -87.5% | 75 | -83.6% | 0.00% | – |
| Q1 2017 | $8,000 | -96.5% | 457 | -97.8% | 0.00% | – |
| Q4 2016 | $227,000 | +710.7% | 20,658 | +1058.6% | 0.00% | – |
| Q3 2016 | $28,000 | +27.3% | 1,783 | -17.7% | 0.00% | – |
| Q2 2016 | $22,000 | -72.8% | 2,166 | -65.5% | 0.00% | – |
| Q1 2016 | $81,000 | +68.8% | 6,281 | +171.7% | 0.00% | – |
| Q4 2015 | $48,000 | – | 2,312 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |